Abstract
Purpose
To determine how adipose-derived stromal vascular fraction (SVF) injection following core decompression (CD) and biochemistry artificial bone graft implantation affects outcomes in patients with osteonecrosis of the femoral head (ONFH).
Methods
A total of 19 patients (28 hips) with stage I-IIIA ONFH received adipose-derived SVF injection and combined core decompression and biochemistry artificial bone graft implantation, followed up for a minimum of two years. Disease progression was evaluated according to the Association Research Circulation Osseous (ARCO) staging system, and the change of the ratio of the necrotic volume to femoral head volume was calculated with MRI before and after operation.
Results
At the last follow-up, 15 hips remained stable, and 13 hips had a progression, according to the ARCO staging system. A total of eight hips (5 with ARCO stage II and 3 with staged IIIA at baseline) progressed to post-collapse stage (stage IIIB-IV). In total, seven of eight hips with post-collapse stage and one with IIIA stage at follow-up converted to THAs in an average of 17.5 months (range, 11–68 months) postoperatively. The mean ratio of the necrotic lesion volume to the femoral head significantly decreased in hips with ARCO stage I (17.9 ± 3.0% to 9.8 ± 1.3%, p = 0.012, Δ necrosis ratio = 8.1 ± 4.2%) and stage II (22.7 ± 6.3% to 17.1 ± 9.4%, p = 0.001, Δ necrosis ratio = 5.7 ± 6.6%) at baseline. For the eight hips that progressed to post-collapse stage, the mean necrosis ratio increased from 27.4 ± 5.4% to 31.1 ± 4.0% (p = 0.146), Δ necrosis ratio = − 3.7 ± 3.9%. For the other 20 hips radiological survived, the mean necrosis ratio improved from 19.9 ± 4.4% to 11.8 ± 3.3% (p < 0.001), with Δ necrosis ratio = 8.1 ± 4.9%.
Conclusion
Adipose-derived SVF injection following core decompression and biochemistry artificial bone graft implantation is safe and could effectively repair the necrosis lesion and delay disease progression in patients with early-stage ONFH.
Similar content being viewed by others
Data availability
The data that support the findings of this study are available upon request from the corresponding author.
Code availability
Not applicable.
References
Mont MA, Hungerford DS (1995) Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg Am 77:459–474. https://doi.org/10.2106/00004623-199503000-00018
Lieberman JR (2004) Core decompression for osteonecrosis of the hip Clin Orthop Relat Res 29–33. https://doi.org/10.1097/00003086-200401000-00006
Hernigou P, Beaujean F (2002) Treatment of osteonecrosis with autologous bone marrow grafting Clin Orthop Relat Res 14–23. https://doi.org/10.1097/00003086-200212000-00003
Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7:211–228. https://doi.org/10.1089/107632701300062859
Wyles CC, Houdek MT, Crespo-Diaz RJ, Norambuena GA, Stalboerger PG, Terzic A, Behfar A, Sierra RJ (2015) Adipose-derived mesenchymal stem cells are phenotypically superior for regeneration in the setting of osteonecrosis of the femoral head. Clin Orthop Relat Res 473:3080–3090. https://doi.org/10.1007/s11999-015-4385-8
Bourin P, Bunnell BA, Casteilla L, Dominici M, Katz AJ, March KL, Redl H, Rubin JP, Yoshimura K, Gimble JM (2013) Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy 15:641–648. https://doi.org/10.1016/j.jcyt.2013.02.006
Fodor PB, Paulseth SG (2016) Adipose derived stromal cell (ADSC) injections for pain management of osteoarthritis in the human knee joint. Aesthet Surg J 36:229–236. https://doi.org/10.1093/asj/sjv135
Yokota N, Yamakawa M, Shirata T, Kimura T, Kaneshima H (2017) Clinical results following intra-articular injection of adipose-derived stromal vascular fraction cells in patients with osteoarthritis of the knee. Regen Ther 6:108–112. https://doi.org/10.1016/j.reth.2017.04.002
Yokota N, Hattori M, Ohtsuru T, Otsuji M, Lyman S, Shimomura K, Nakamura N (2019) Comparative clinical outcomes after intra-articular injection with adipose-derived cultured stem cells or noncultured stromal vascular fraction for the treatment of knee osteoarthritis. Am J Sports Med 47:2577–2583. https://doi.org/10.1177/0363546519864359
Hong Z, Chen J, Zhang S, Zhao C, Bi M, Chen X, Bi Q (2019) Intra-articular injection of autologous adipose-derived stromal vascular fractions for knee osteoarthritis: a double-blind randomized self-controlled trial. Int Orthop 43:1123–1134. https://doi.org/10.1007/s00264-018-4099-0
Gangji V, Hauzeur JP, Schoutens A, Hinsenkamp M, Appelboom T, Egrise D (2003) Abnormalities in the replicative capacity of osteoblastic cells in the proximal femur of patients with osteonecrosis of the femoral head. J Rheumatol 30:348–351
Hernigou P, Dubory A, Homma Y, Guissou I, FlouzatLachaniette CH, Chevallier N, Rouard H (2018) Cell therapy versus simultaneous contralateral decompression in symptomatic corticosteroid osteonecrosis: a thirty year follow-up prospective randomized study of one hundred and twenty five adult patients. Int Orthop 42:1639–1649. https://doi.org/10.1007/s00264-018-3941-8
Hauzeur JP, De Maertelaer V, Baudoux E, Malaise M, Beguin Y, Gangji V (2018) Inefficacy of autologous bone marrow concentrate in stage three osteonecrosis: a randomized controlled double-blind trial. Int Orthop 42:1429–1435. https://doi.org/10.1007/s00264-017-3650-8
Riddle DL, Stratford PW (2013) Unilateral vs bilateral symptomatic knee osteoarthritis: associations between pain intensity and function. Rheumatology (Oxford) 52:2229–2237. https://doi.org/10.1093/rheumatology/ket291
Yoon PW, Kang JY, Kim CH, Lee SJ, Yoo JJ, Kim HJ, Kang SK, Min JH, Yoon KS (2021) Culture-expanded autologous adipose-derived mesenchymal stem cell treatment for osteonecrosis of the femoral head. Clin Orthop Surg 13:37–46. https://doi.org/10.4055/cios20128
Nan K, Zhang Y, Zhang X, Li D, Zhao Y, Jing Z, Liu K, Shang D, Geng Z, Fan L (2021) Exosomes from miRNA-378-modified adipose-derived stem cells prevent glucocorticoid-induced osteonecrosis of the femoral head by enhancing angiogenesis and osteogenesis via targeting miR-378 negatively regulated suppressor of fused (Sufu). Stem Cell Res Ther 12:331. https://doi.org/10.1186/s13287-021-02390-x
Veronesi F, Maglio M, Tschon M, Aldini NN, Fini M (2014) Adipose-derived mesenchymal stem cells for cartilage tissue engineering: state-of-the-art in in vivo studies. J Biomed Mater Res A 102:2448–2466. https://doi.org/10.1002/jbm.a.34896
Wang X, Wang Y, Gou W, Lu Q, Peng J, Lu S (2013) Role of mesenchymal stem cells in bone regeneration and fracture repair: a review. Int Orthop 37:2491–2498. https://doi.org/10.1007/s00264-013-2059-2
Schiavone Panni A, Vasso M, Braile A, Toro G, De Cicco A, Viggiano D, Lepore F (2019) Preliminary results of autologous adipose-derived stem cells in early knee osteoarthritis: identification of a subpopulation with greater response. Int Orthop 43:7–13. https://doi.org/10.1007/s00264-018-4182-6
Natali S, Screpis D, Farinelli L, Iacono V, Vacca V, Gigante A, Zorzi C (2021) The use of intra-articular injection of autologous micro-fragmented adipose tissue as pain treatment for ankle osteoarthritis: a prospective not randomized clinical study. Int Orthop 45:2239–2244. https://doi.org/10.1007/s00264-021-05093-3
Lin K, Matsubara Y, Masuda Y, Togashi K, Ohno T, Tamura T, Toyoshima Y, Sugimachi K, Toyoda M, Marc H, Douglas A (2008) Characterization of adipose tissue-derived cells isolated with the celution system. Cytotherapy 10:417–426. https://doi.org/10.1080/14653240801982979
Funding
This study was supported by grants from the Key R&D projects of Zhejiang Province (CN) (2021C03078).
Author information
Authors and Affiliations
Contributions
All authors contributed to the study’s conception and design. Material preparation, data collection, and analysis were performed by Zheping Hong and Yin Zhang. The study was designed by Zheping Hong and Qing Bi. The first draft of the manuscript was written by Zheping Hong. Jihang Chen and Qing Bi reviewed and edited the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethical approval
This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Zhejiang Provincial People’s Hospital (2021QT276).
Consent to participate
Informed consent was obtained from all individual participants included in the study.
Consent for publication
Not applicable.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Hong, Z., Zhang, Y., Chen, J. et al. Adipose-derived stromal vascular fraction injection following core decompression and biochemistry artificial bone graft implantation in osteonecrosis of the femoral head. International Orthopaedics (SICOT) 47, 1481–1486 (2023). https://doi.org/10.1007/s00264-023-05792-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00264-023-05792-z